XML 112 R99.htm IDEA: XBRL DOCUMENT v3.21.2
Debt - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 19, 2021
Oct. 02, 2019
May 11, 2016
Sep. 30, 2021
Mar. 20, 2021
Debt          
Unamortized premium       $ 404  
Deerfield Private Design Fund III LP          
Debt          
Debt borrowing structure (as a percent)     66.67%    
Deerfield Partners          
Debt          
Debt borrowing structure (as a percent)     33.33%    
Neos Therapeutics, Inc. | Loan Agreement          
Debt          
Maximum borrowing capacity   $ 25,000      
Maximum borrowing capacity portion available for short-term swingline loans   $ 2,500      
Percentage of eligible accounts receivable against which short-term swingline loans may be made   85.00%      
Unused capacity commitment fee percentage   0.50%      
Period of notice required before prepaying the debt instrument   5 days      
Interest expense       100  
Outstanding amount       4,500  
Neos Therapeutics, Inc. | Loan Agreement | Event Occurs On or Before October 2, 2021          
Debt          
Prepayment fee percentage   1.00%      
Neos Therapeutics, Inc. | Loan Agreement | Event Occurs After October 2, 2021 but Before May 11, 2022          
Debt          
Prepayment fee percentage   0.50%      
Neos Therapeutics, Inc. | Loan Agreement | London Interbank Offered Rate (LIBOR)          
Debt          
Basis spread on variable rate   4.50%      
Neos Therapeutics, Inc. | Senior secured credit facility, due on May 11, 2022          
Debt          
Face amount     $ 60,000    
Percentage of prepayment premium on principal prepaid 6.25%        
Long-term debt $ 15,600        
Long-term debt current maturities $ 600        
Interest rate 12.95%        
Cash on deposit $ 5,000        
Repayments of debt 15,000        
Carrying amount of the remaining outstanding debt 16,600     15,000  
Fair value of the remaining outstanding debt         $ 17,400
Non-refundable exit fee $ 1,000        
Unamortized premium       404 $ 800
Interest expense       $ 300